All Product News

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%. Aurobindo Pharma’s Adapalene and Benzoyl Peroxide Topical Gel,  are an AB-rated generic equivalent to the reference listed drug (RLD), Epiduo® Forte Topical Gel, manufactured by […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Bupropion Hydrochloride Extended-Release Tablets USP (XL), 150 mg and 300 mg. Aurobindo Pharma’s Bupropion Hydrochloride Extended-Release Tablets USP (XL),  are an AB-rated generic equivalent to the reference listed drug (RLD), Wellbutrin XL® […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Etodolac Tablets USP, 400 mg and 500 mg. Aurobindo Pharma’s Etodolac Tablets USP, are an AB-rated generic equivalent to the reference listed drug (RLD), Lodine® Tablets, manufactured by Wyeth Pharmaceuticals Inc. Etodolac […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Icosapent Ethyl Capsules, 1 gram. Aurobindo Pharma’s Icosapent Ethyl Capsules, are an AB-rated generic equivalent to the reference listed drug (RLD), Vascepa Capsules, manufactured by Amarin Pharmaceuticals Ireland, Limited. Icosapent Ethyl Capsules […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Cephalexin For Oral Suspension USP, 125 mg/5 mL and 250 mg/5 mL. Aurobindo Pharma’s Cephalexin For Oral Suspension, are an AB-rated generic equivalent to the reference listed drug (RLD), Keflex for Oral […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Tofacitinib Tablets, 5 mg and 10 mg. Aurobindo Pharma’s Tofacitinib Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Xeljanz Tablets, manufactured by PF Prism C.V. Tofacitinib Tablets are […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Eluxadoline Tablets, 75 mg and 100 mg. Aurobindo Pharma’s Eluxadoline Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Viberzi Tablets, manufactured by AbbVie Inc. Eluxadoline Tablets are indicated […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Canagliflozin Tablets, 100 mg and 300 mg. Aurobindo Pharma’s Canagliflozin Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Invokana Tablets, manufactured by Janssen Pharmaceuticals, Inc. Canagliflozin Tablets are […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Pirfenidone Capsules USP, 267 mg. Aurobindo Pharma’s Pirfenidone Capsules, are an AB-rated generic equivalent to the reference listed drug (RLD), Esbriet Capsules, manufactured by Legacy Pharma, Inc. Pirfenidone Capsules are indicated for […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL. Aurobindo Pharma’s Glycerol Phenylbutyrate Oral Liquid, are an AB-rated generic equivalent to the reference listed drug (RLD), Ravicti Oral Liquid, manufactured by Horizon Therapeutics […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Dapagliflozin Tablets, 5 mg and 10 mg. Aurobindo Pharma’s Dapagliflozin Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), Farxiga Tablets, manufactured by AstraZeneca AB. Dapagliflozin Tablets are indicated […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Dapagliflozin and Metformin Hydrochloride Extended- Release Tablets, 5 mg/ 500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg. Aurobindo Pharma’s Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets, are an AB-rated […]